Cargando…
Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines
Rho GTPases play a key role in the regulation of multiple essential cellular processes, including actin dynamics, gene transcription and cell cycle progression. Aberrant activation of Rac1, a member of Rho family of small GTPases, is associated with tumorigenesis, cancer progression, invasion and me...
Autores principales: | Cardama, Georgina A, Comin, Maria J, Hornos, Leandro, Gonzalez, Nazareno, Defelipe, Lucas, Turjanski, Adrian G, Alonso, Daniel F, Gomez, Daniel E, Menna, Pablo Lorenzano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104455/ https://www.ncbi.nlm.nih.gov/pubmed/24066799 http://dx.doi.org/10.2174/18715206113136660334 |
Ejemplares similares
-
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells
por: Cardama, Georgina A, et al.
Publicado: (2014) -
Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models
por: Cardama, Georgina A., et al.
Publicado: (2022) -
Pharmacological Rac1 inhibitors with selective apoptotic activity in human acute leukemic cell lines
por: Cabrera, Maia, et al.
Publicado: (2017) -
Computational and in vitro Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity
por: González, Nazareno, et al.
Publicado: (2020) -
Rac‐GTPases and Rac‐GEFs in neutrophil adhesion, migration and recruitment
por: Pantarelli, Chiara, et al.
Publicado: (2018)